Come and join us across the globe
Sign In

Treatment of posterior circulation fusiform aneurysms using the pipeline embolisation device

Last update on November 28, 2022

Find out how Dr Karashash Menlibayeva treated a 56-year-old female patient with posterior circulation fusiform aneurysms.

Case presentation

Patient

  • 56-year-old female patient
  • Main complaint: right hemiparesis (motor examination grade 2/5)
  • History: infarction consistent with embolic aetiology 2 years ago
  • Examination: MRI and DSA
  • Diagnosis: unruptured right vertebral fusiform aneurysm (VFA) involving the basilar and the left vertebral artery

 

Axial Т2 MR images

Figure 1, A and B: axial Т2 MR images demonstrating multiple small areas of infarction consistent with embolic etiology.

3D CT angiography

3D CT angiography reconstruction shows a VFA involving the left vertebral artery and the basilar artery. A lateral aneurysm originating from the basilar artery is seen. Microaneurysm in P1 segment of the right PCA. 

Anteroposterior and Lateral DSA

Anteroposterior and lateral DSA demonstrates lateral basilar artery aneurysm.

The patient was treated with  PEDs

The patient received oral aspirin (300 mg) and Ticagrelor (180 mg) 4 hours before surgery, and 5000 U of heparin was used during surgery.

The patient was treated with PEDs (4 × 25 mm).

Left vertebral artery occluded by coiling

Left vertebral artery occluded by coiling above PICA.

complete occlusion of the VFA

Right VA

Left VA

Follow-up at 3 months DSA demonstrates complete occlusion of the VFA.

DSA from right vertebral artery

Follow-up after 12 months. DSA from right vertebral artery.

DSA from left vertebral artery

Follow-up after 12 months. DSA from left vertebral artery.

Conclusions
  • Microsurgical treatment of VFAs can be difficult and associated with high rates of morbidity and mortality.
  • Treatment with the pipeline embolization device may provide an effective and less invasive alternative to microsurgical intervention.
On the same subject
Come and join us across the globe